Entourage_logo (002).jpg
Entourage Health Reports Q3 Financial Results with $14.9 Million Record Revenue Representing 94% YOY Increase and Fourth Consecutive Quarter of Growth
November 16, 2021 07:00 ET | Entourage Health Corp.
Adult-Use net revenue for the quarter increased by 102% compared to last yearSales, general and administrative costs decreased by 16% compared to last yearStrategic acquisition of craft cultivator...
Entourage_logo (002).jpg
Entourage Health Announces Preliminary Q3 Record Revenue of $14.7 Million and Confirms Financial Results Call to be Held on November 16, 2021 at 10 a.m. ET
October 19, 2021 08:36 ET | Entourage Health Corp.
Fourth consecutive quarter of growth attributed to expanding market share and record salesCompany also completes amendments to its $39 million senior secured credit facility TORONTO, Oct. 19, 2021 ...
Entourage_logo (002).jpg
Entourage Health Reports Q2 Financial Results with $13.8 Million Record Revenue Representing 92% YOY Increase and Third Consecutive Quarter of Growth
August 10, 2021 07:05 ET | Entourage Health Corp.
Continued record sales of higher-margin products in all channels drives 29% gross marginFulfilled record purchase orders from every province, focusing on top-performing products resulting in a 159%...
Entourage_logo (002).jpg
Entourage Health Announces Preliminary Record Q2 Revenues of $13.6 Million and Confirms Financial Results Call to be Held on August 10, 2021 at 10 a.m. ET
July 20, 2021 08:05 ET | Entourage Health Corp.
TORONTO, July 20, 2021 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:WDDMF) (FSE:4WE) (“Entourage” or the “Company”), is pleased to announce preliminary...
WeedMD logo.jpg
WeedMD Reports First Quarter 2021 Financial Results with 102% Record Increase in Sequential Net Revenue Growth
June 29, 2021 07:15 ET | WeedMD Rx Inc.
Total revenue (before excise duties) of $12.9 million in Q1 2021, represents over 7% favourability over the $12.0 million Q1 2021 guidance previously providedNet revenue of $10.3 million in Q1 2021,...
WeedMD logo.jpg
WeedMD Reports Fiscal Year 2020 Financial Results and First Quarter 2021 Preliminary Gross Revenue of $12 Million
May 31, 2021 07:24 ET | WeedMD Rx Inc.
Net revenue increased 41% YOY to $29.4 million for the full year ended December 31, 2020Kilograms harvested in 2020 grew 88% over prior year to 33,751 with more Grade A flowerWeighted average cost per...
WeedMD logo.jpg
WeedMD to Host Fiscal Year End 2020 Conference Call on May 31st
May 21, 2021 08:18 ET | WeedMD Rx Inc.
Company financials to be filed after market on May 28, 2021 and operational outlook to be provided during call, including first quarter 2021 record milestones achieved TORONTO, May 21, 2021 (GLOBE...
WeedMD logo.jpg
WeedMD Inc. Granted Management Cease Trade Order
May 03, 2021 15:46 ET | WeedMD Rx Inc.
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, May 03, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or...
WeedMD logo.jpg
WeedMD Announces Delayed Filing of its 2020 Annual Financial Disclosure
April 21, 2021 09:47 ET | WeedMD Rx Inc.
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, April 21, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or...
WeedMD logo.jpg
WeedMD to Host Fiscal Year-End 2020 Conference Call on April 30, 2021
April 09, 2021 09:02 ET | WeedMD Rx Inc.
TORONTO, April 09, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis,...